Neuroscience of Nicotine

HIV Depression Gambling Cannabis Cocaine Anxiety Cigarette-smoking Drug Addiction Abstinence Alcohol Evidence Mice Cigarette Brain Crack-cocaine Desire Drug-use Adolescent Marijuana Clinical trials Cognition Exercise Gene expression. Girls Inflammation Mass spectrometry Memory Mental disorders Multiple Sclerosis Nanoparticles. Cigarettes Neurodegenerative Diseases Analgesia Journals Imaging Autonomic nervous system Age Incubation Cell culture Dopamine Nicotine Blood-brain barrier Antioxidants Cigarette smoke Nicotine addiction Books Amyotrophic lateral sclerosis Delirium Attention Affect Anhedonia Female Ibogaine Astrocytes Naltrexone Calcium Signaling Executive Function Epigenetics Neuroimaging Functional Neuroimaging animal model Eye tracking Neurogenesis Electronic cigarettes Genome-Wide Association Study Alzheimer's disease Neuroprotection Histone acetylation Neurodegenerative disease Cognitive behavior Enhancer Dependence Alternatives MRNA Cognitive function Nac Neuromodulation Kindling Neuroinflammation Attention deficit hyperactivity disorder (ADHD) Mechanism Functional magnetic resonance imaging Environmental Tobacco Smoke GWAS Neuronal progenitor cell Knockout Interoception N-acetylcysteine Motoneuron Multidisciplinary Dose-response Cerebrovascular L-Dopa Lou Gehrig's Disease D3 Menthol Hypocretin Disordered Gambling Mitophagy Nicotinic Acetylcholine Receptors Biomarker Allosteric Modulation Calcium channel Cravings Excitotoxicity Corticotropin-releasing factor Gene regulation HPA axis Neuropathic Pain Neuropsychiatric Disorders FMRI Addictive behavior Nicotine dependence Default Mode Network Firing Craving Desensitization ICSS LDT 6-Hydroxy-l-nicotine Aberrant learning ACh-glutamate corelease Acute Exercise Acute nicotine withdrawal Additive genetic efficiency score Alpha 3 (a3) Attentional bias retraining Attentional Bias antinociception Angiotensin-converting enzyme gene Antinicotine antibody Behavioral sensitization Beta 2 (ß2) Alpha4 beta2 nicotinic acetylcholine receptor bupropion CFLP mice Chronic nicotine administration Closed-channel blockade Cholinergic receptors Cav1.2 Cigarettes consumption Continuous Abstinence Cognitive Remediation Training Blood hemostasis Conditioned Place Preference Behavioral Counseling Conjugate Vaccine CRF Co-occurrence CYP2A6 Cigarette excise taxes Corticostriatal plasticity Brain renin-angiotensin system Cotinine Cutoff value Dopamine neuron Cav1.3 Cell death mechanism Conditioned place aversion Depressive-like symptoms Chronic treatment D2 emotional behavior Comorbid addictions Gene Fallypride Experimental animal models for drug abuse Gambling Disorder Histone Deacetylase Inhibitor D1 Denicotinized cigarettes Interference control interoceptive Instrumental methods of analysis Dopamine and cAMP-regulated phosphoprotein 32kDa Dopaminergic pathways Dopaminergic type 1 receptors Indirect pathway Insertion/deletion polymorphism Drug discrimination Junctional and extrajunctional receptors Long-duration response F-DOPA Nicotinic acetylcholine receptor agonists Nicotinic blockers L-type calcium channel Neuroadaptation Nicotine Reward Nicotinic acetylcholine receptor Nicotine metabolism Nicotine vaccine Nicotinic acetylcholine receptor subtypes FAAH inhibitor Modified Stroop Muscle-type nicotinic receptors Healthy subjects nAChRs Nicotine withdrawal delirium Histone acetyltransferase Habenula-IPN Neuronal remodeling HIV-associated neurocognitive disorders neurotrophic factors Nicotinic cholinergic receptor Glutamate uptake Hypocholinergic state Interpeduncular Nucleus Inflammatory pain Medial habenula “Light” cigarettes Neuroadaptations Nicotine dependence treatment Nicotine patch Mesolimbic system Nicotine Replacement Therapy Microscopic reversibility